Zacks Research downgraded Liquidia Technologies (NASDAQ: LQDA) from hold to strong sell on September 24, 2026.
The rating action follows concerns regarding the competitive landscape for Yutrepia, the company's treatment for pulmonary arterial hypertension.
Analysts suggest that intensifying market competition may impact the firm's future growth prospects. The research note did not provide specific internal reasons for the strong sell recommendation.